HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.7B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
Period EndPretax margin (%) YoY (%)
Feb 28, 202614.7-4.54%
Feb 28, 202515.4+10.99%
Feb 29, 202413.9+10.86%
Feb 28, 202312.5+18.95%
Feb 28, 202210.5+1.79%
Feb 28, 202110.3-43.17%
Feb 29, 202018.2+5.76%
Feb 28, 201917.2-10.02%
Feb 28, 201819.1-1.08%
Feb 28, 201719.3+11.59%
Feb 29, 201617.3-4.79%
Feb 28, 201518.2-5.30%
Feb 28, 201419.2-17.10%
Feb 28, 201323.1-4.76%
Feb 29, 201224.3
AI Chat